Su Bei-Bei, Zhou Shu-Wei, Gan Cai-Bin, Zhang Xiao-Ning
Department of Dermatology, Xinxiang Central Hospital, Xinxiang, Henan, People's Republic of China.
Department of Head, Neck, and Breast Surgery, Xinxiang Central Hospital, Xinxiang, Henan, People's Republic of China.
J Surg Res. 2016 Jun 15;203(2):434-40. doi: 10.1016/j.jss.2016.03.021. Epub 2016 Mar 19.
Increasing evidence has suggested that miR-330-5p can function as a tumor suppressor in different types of cancers. However, the effects and underlying mechanisms of miR-330-5p in the development of cutaneous malignant melanoma (CMM) remain largely unknown. The aim of the present study was to investigate the role of miR-330-5p in CMM and to determine the molecular mechanisms underlying its action.
The expression level of miR-330-5p was detected in 26 cases of primary CMM tissues and cell lines by real-time quantitative polymerase chain reaction. We also assessed whether overexpression of miR-330-5p influences in vitro cell proliferation, invasion, and migration. Western blotting analysis was used to detect the influence of miR-330-5p on the targets, and Pearson analysis was used to calculate the correlation between the expression of targets gene and miR-330-5p in CMM tissues.
Our study showed that miR-330-5p was downregulated in CMM tissues (P = 0.010) and cell lines (P < 0.05), and patients with high mitotic activity showed lower miR-330-5p expression levels (P = 0.002). Enforced expression of miR-330-5p inhibits malignant CMM cells proliferation and migration and led to downregulation of the TYR and PDIA3 protein. Moreover, the expression level of miR-330-5p in CMM tissues showed inverse relationship with the expression level of TYR and PDIA3 protein.
In conclusion, our findings suggested that miR-330-5p represents a potential tumor-suppressive miRNA and plays an important role in CMM progression by suppressing TYR and PDIA3 expression.
越来越多的证据表明,miR-330-5p在不同类型的癌症中可作为一种肿瘤抑制因子发挥作用。然而,miR-330-5p在皮肤恶性黑色素瘤(CMM)发生发展中的作用及其潜在机制仍不清楚。本研究旨在探讨miR-330-5p在CMM中的作用,并确定其作用的分子机制。
采用实时定量聚合酶链反应检测26例原发性CMM组织和细胞系中miR-330-5p的表达水平。我们还评估了miR-330-5p的过表达是否会影响体外细胞的增殖、侵袭和迁移。采用蛋白质免疫印迹分析检测miR-330-5p对靶标的影响,并用Pearson分析计算靶标基因表达与CMM组织中miR-330-5p表达之间的相关性。
我们的研究表明,miR-330-5p在CMM组织(P = 0.010)和细胞系(P < 0.05)中表达下调,有丝分裂活性高的患者miR-330-5p表达水平较低(P = 0.002)。miR-330-5p的过表达抑制了恶性CMM细胞的增殖和迁移,并导致TYR和PDIA3蛋白表达下调。此外,CMM组织中miR-330-5p的表达水平与TYR和PDIA3蛋白的表达水平呈负相关。
总之,我们的研究结果表明,miR-330-5p是一种潜在的肿瘤抑制性微小RNA,通过抑制TYR和PDIA3的表达在CMM进展中发挥重要作用。